missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ BTLA Chimeric Recombinant Armenian Hamster Monoclonal Antibody (HMBT-6B2)

Description
This antibody is specific for B and T lymphocyte attenuator (BTLA), which functions as a negative regulator of T cell activation and proliferation, and attenuates B cell proliferation upon associating with its known ligand, herpes virus entry mediator (HVEM).
BTLA or B and T-lymphocyte attenuator is a member of the co-inhibitory receptors of the CD28 superfamily. BTLA is a lymphocyte inhibitory receptor which inhibits lymphocytes during immunes responses. BTLA is constitutively expressed on most CD4+ and CD8+ T cells and its expression progressively decreases upon T cell activation. It remains expressed on Th1 cells, but not Th2 cells. BTLA is a unique co-receptor that interacts with the tumor necrosis factor receptor superfamily member herpesvirus entry mediator (HVEM). This interation is an important pathway regulating lymphocyte activation and/or homeostasis in the immune response.
Specifications
Specifications
| Antigen | BTLA Chimeric |
| Applications | Flow Cytometry, Functional Assay, Inhibition Assays, Immunoprecipitation, Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | HMBT-6B2 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% ProClin 300 |
| Gene | BTLA |
| Gene Accession No. | Q7TSA3 |
| Gene Alias | A630002H24; B and T lymphocyte associated; B and T lymphocyte associated protein; B and T lymphocyte attenuator; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; BTLA; BTLA_HUMAN; BTLA1; CD272; CD272 antigen; FLJ16065; MGC129743 |
| Show More |